
MDS Plus 100mg Injection
Marketer
Adley Formulations
Salt Composition
Azacitidine (100mg)
Overview MDS Plus 100mg Injection
Azacitidine 100mg Injection is indicated in the management of certain hematological malignancies. It's employed in the treatment of adult patients across all Myelodysplastic Syndrome (MDS) subtypes. Additional applications may be determined by a physician. Administration of Azacitidine 100mg Injection occurs via injection under strict medical oversight. Dosage frequency and amount are physician-determined, contingent upon the specific condition being treated and subject to adjustment. Adherence to the prescribed regimen is crucial; incorrect usage or overdose can result in severe adverse events. Therapeutic benefits may not manifest immediately; consistent use is generally advised unless otherwise directed by the attending physician. Frequently reported side effects include injection site inflammation (pain, edema, erythema), emesis, asthenia, and nausea. Prompt physician notification is warranted should these effects become problematic. Strategies for mitigation may exist. Vaccination during treatment requires prior physician consultation. Routine hematological monitoring, including evaluation of cardiac, hepatic, and renal function, is necessary. Pre-treatment disclosure of any pre-existing hepatic or renal impairment, or concurrent use of antimicrobial medications, is mandatory. Potential drug interactions necessitate comprehensive disclosure of all medications to the prescribing physician. This medication is contraindicated during gestation and lactation.
Uses of MDS Plus 100mg Injection
Myelodysplastic syndrome and its management in hematologic oncology
Major Benefits of MDS Plus 100mg Injection:
This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.
Common Side effects of MDS Plus 100mg Injection:
- Injection site reactions (pain, swelling, redness)
- Vomiting
- Weakness
- Nausea
- Decreased potassium level in blood
- Bruise
- Fever
- Chills
- Diarrhea
- Constipation
How to use MDS Plus 100mg Injection:
This medication will be administered by your physician or registered nurse; self-medication is strictly prohibited.
How MDS Plus 100mg Injection works:
Leukemia patients receive MDS Plus 100mg Injection, an antineoplastic agent. Its mechanism of action involves disrupting the DNA and RNA of cancerous cells, thereby inducing cell death and promoting healthy maturation of blood cells within the bone marrow.
SAFETY ADVICE
AlcoholCONSULT YOUR DOCTOR
Alcohol consumption alongside MDS Plus 100mg Injection may pose unknown risks. Seek medical advice before combining them.
PregnancyCONSULT YOUR DOCTOR
Administering MDS Plus 100mg Injection during pregnancy is contraindicated due to established fetal risks. Exceptions may exist in critical circumstances where a physician deems the potential benefits outweigh the hazards. Physician consultation is essential.
Breast feedingUNSAFE
Administering MDS Plus 100mg Injection while breastfeeding is contraindicated. Evidence indicates potential infant harm from the medication.
DrivingUNSAFE
The injectable medication MDS Plus 100mg may induce adverse reactions, potentially impairing driving ability. Fatigue is one such possible side effect that could compromise safe driving.
KidneyCAUTION
Exercise caution when administering MDS Plus 100mg Injection to individuals with impaired renal function. Dosage modification for MDS Plus 100mg Injection may be necessary. Physician consultation is advised.
LiverCAUTION
Patients with liver impairment should use MDS Plus 100mg Injection cautiously, potentially requiring dosage modification. Physician consultation is advised. MDS Plus 100mg Injection is contraindicated in patients exhibiting advanced hepatocellular carcinoma.
What if you forget to take MDS Plus 100mg Injection :
NA
Facts to Know About MDS Plus 100mg Injection
Label | Value |
---|---|
Chemical Type | Pyrimidine Nucleoside Analog |
Developing Habits | No. |
Treatment Category | Cancer Medications |
Action Class | Metabolic Inhibitors |